跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 822 条关于
“XBB.1.16”
全部
822
临床试验
291
药物
347
机构
5
资讯
179
2年前
Novavax COVID-19 Vaccine Receives FDA Emergency Use Authorization for 2023-2024 Formula
去年
Novel Trivalent COVID-19 Vaccine Shows Robust Cross-Protection Against XBB Variants
3年前
FDA Authorizes Second Omicron Booster for High-Risk Groups, Simplifies COVID-19 Vaccine Strategy
3年前
FDA Warns Evusheld May Be Ineffective Against COVID-19 Subvariant XBB.1.5
3年前
Moderna Submits FDA Application for Updated COVID-19 Vaccine Targeting XBB Variants
3年前
FDA Approves Updated COVID-19 Vaccines from Pfizer and Moderna Targeting XBB.1.5 Omicron Variant
去年
Novavax's XBB.1.5-Based COVID-19 Booster Shows Superior Immune Response in Phase 2/3 Trial
2年前
FDA Revokes Emergency Use Authorization for Evusheld Due to Variant Ineffectiveness
2年前
Updated COVID-19 Vaccines Targeting JN.1 and KP.2 Variants Show Promise
去年
Updated COVID-19 Vaccines Show Strong Protection Against Severe Illness in Comprehensive CDC Study
第 1 页,共 18 页
上一页
下一页